脂蛋白和大动脉狭窄:实际见解
Kyriakos Dimitriadis1, Konstantinos G Kyriakoulis1, Nikolaos Pyrpyris1
1First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.
概括
高水平的脂蛋白 (Lp) 与大动脉狭窄 (AS) 的发展和进展有关. 降低Lp (a) 的疗法可能为AS患者提供新的治疗策略.
科学领域:
- 心血管医学 心血管医学
- 生物化学 生物化学
背景情况:
- 脂蛋白 (Lp) 越来越多地被认为在心血管疾病中的作用.
- 升高的Lp (a) 水平与不良的心血管结果有关.
研究的目的:
- 审查有关大动脉狭窄 (AS) 和Lp (a) 之间的关系的当前文献和研究.
- 为基础和临床科学家提供最新数据.
主要方法:
- 对观察性和遗传学研究的综合文献综述.
- 分析AS病原和Lp (a) 之间的相互作用.
主要成果:
- Lp (a) 显著促进了AS的病变发生.
- 患有AS的患者表现出更高的Lp (a) 水平.
- 增加Lp (a) 与AS发展的风险更高有关.
结论:
- 升高的Lp (a) 预测AS的存在,发展和进展.
- Lp(a) 可以提供对生物假体门功能的见解.
- 对Lp (a) 降低剂的进一步研究对于AS治疗至关重要.
相关概念视频
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Atherosclerosis I: Introduction
933
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
933
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
475
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
475
Aortic Regurgitation III: Medical Management
401
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
401
Peripheral Artery Disease I: Introduction
320
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
320
Aneurysm II: Clinical Manifestations and Diagnostic Studies
308
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
308


